RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

NCT00002462 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

615

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
DRUG: doxorubicin hydrochloride
DRUG: mechlorethamine hydrochloride
DRUG: prednisone
DRUG: procarbazine hydrochloride
DRUG: vinblastine sulfate
DRUG: vincristine sulfate
RADIATION: low-LET cobalt-60 gamma ray therapy
RADIATION: low-LET photon therapy
RADIATION: radiation therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC